Literature DB >> 16115136

Complimentary and alternative medicine use among patients starting warfarin.

Nadine A Ramsay1, Martin W Kenny, Graham Davies, Jignesh P Patel.   

Abstract

The use of complimentary and alternative medicines (CAM) among the UK population is on the increase. For patients requiring warfarin therapy, it is important to maintain an adequate and safe level of anticoagulation. As some forms of CAM can interact with warfarin, it is imperative that any patient considered for warfarin, is asked about their use of CAM. Our report describes the incidence and type of CAM usage among patients about to start or recently commenced on warfarin therapy attending our outpatient anticoagulant clinic. All patients attending clinic for the first time were seen by a pharmacist. A retrospective analysis of the pharmaceutical care plans for all patients seen during 2003 were analysed regarding the degree of CAM usage. Of 631 care plans reviewed, 170 (26.9%) patients were taking some form of CAM. Ninety-nine (58% of all CAM users) were taking a CAM that could interact with warfarin; the commonest forms were cod-liver oil capsules and garlic capsules. We conclude that many patients new to warfarin therapy were significant users of CAM, many of which had the potential to interact with warfarin. By taking a full drug history, potential CAM/warfarin interactions could be avoided.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16115136     DOI: 10.1111/j.1365-2141.2005.05689.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  17 in total

1.  Repeat adverse drug reactions causing hospitalization in older Australians: a population-based longitudinal study 1980-2003.

Authors:  Min Zhang; C D'Arcy J Holman; David B Preen; Kate Brameld
Journal:  Br J Clin Pharmacol       Date:  2007-02       Impact factor: 4.335

2.  Plenty of pills: polypharmacy prevails in patients of a Danish anticoagulant clinic.

Authors:  Jane Skov; Else-Marie Bladbjerg; Johannes Sidelmann; Marianne Vamosi; Jørgen Jespersen
Journal:  Eur J Clin Pharmacol       Date:  2011-05-12       Impact factor: 2.953

3.  Complementary and alternative medicine: a survey of its use in pediatric cardiology.

Authors:  Denise Adams; Ashley Whidden; Meeri Honkanen; Simon Dagenais; Tammy Clifford; Lola Baydala; W James King; Sunita Vohra
Journal:  CMAJ Open       Date:  2014-10-01

4.  Pharmacodynamic interaction of warfarin with cranberry but not with garlic in healthy subjects.

Authors:  M I Mohammed Abdul; X Jiang; K M Williams; R O Day; B D Roufogalis; W S Liauw; H Xu; A J McLachlan
Journal:  Br J Pharmacol       Date:  2008-06-02       Impact factor: 8.739

Review 5.  Dietary supplements, herbs and oral anticoagulants: the nature of the evidence.

Authors:  Ann K Wittkowsky
Journal:  J Thromb Thrombolysis       Date:  2007-09-29       Impact factor: 2.300

6.  Pharmacists' knowledge and attitudes about natural health products: a mixed-methods study.

Authors:  Nadir Kheir; Hoda Y Gad; Safae E Abu-Yousef
Journal:  Drug Healthc Patient Saf       Date:  2014-01-30

7.  The use of herbal medicines by people with cancer: a qualitative study.

Authors:  Christine Gratus; Sue Wilson; Sheila M Greenfield; Sarah L Damery; Sally A Warmington; Robert Grieve; Neil M Steven; Philip Routledge
Journal:  BMC Complement Altern Med       Date:  2009-05-14       Impact factor: 3.659

8.  Ganoderma lucidum polysaccharides can induce human monocytic leukemia cells into dendritic cells with immuno-stimulatory function.

Authors:  Wing Keung Chan; Christopher Ching Hang Cheung; Helen Ka Wai Law; Yu Lung Lau; Godfrey Chi Fung Chan
Journal:  J Hematol Oncol       Date:  2008-07-21       Impact factor: 17.388

9.  Be wary of "natural" therapy in gynecological surgery.

Authors:  Mark Erian; Glenda McLaren
Journal:  Int J Womens Health       Date:  2013-06-20

Review 10.  Herbal medicines in Brazil: pharmacokinetic profile and potential herb-drug interactions.

Authors:  Andre L D A Mazzari; Jose M Prieto
Journal:  Front Pharmacol       Date:  2014-07-09       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.